Background and Aim: The Inflammatory Bowel Disease Disability Index (IBD-DI) is a measure of disability in inflammatory bowel disease (IBD). The IBD-DI is validated for use as a clinical interview but not for use as a self-report questionnaire. We aimed to validate the IBD-DI for self-report (IBD-DI-SR) and to reduce the number of items, using IBD patients from two centers. Methods: Between April and August 2017, ambulatory IBD patients were recruited from Christchurch Hospital, New Zealand and Concord Hospital, Australia. The IBD-DI clinical interview version was compared with a self-report version. Participants were randomized to do the clinical interview or self-report first. Validation of the IBD-DI-SR involved calculating the correlation coefficient between the clinician completed and self-reported version of the IBD-DI and Cronbach's α of internal consistency of the IBD-DI-SR. To create an itemreduced version, multiple linear regression was used. The R 2 of the model described the overall association between the item-reduced IBD-DI-SR and the IBD-DI. Results: One hundred fourteen patients (57 from Christchurch and 57 from Sydney) completed the IBD-DI-SR validation phase, of whom 63 had Crohn's disease and 51 had ulcerative colitis. The Pearson correlation coefficient between the IBD-DI-SR and IBD-DI is 0.90 (P < 0.001), and Cronbach's α of the IBD-DI-SR was 0.86. The itemreduced version of the IBD-DI-SR consisted of eight questions instead of 28, explaining 77% of the variance. Conclusions: The IBD-DI-SR has demonstrated reliability and validity. The item-reduced IBD-DI-SR is a concise self-report instrument for measuring IBD disability, which makes the IBD-DI more widely usable.
Introduction
Inflammatory bowel diseases (IBD) comprising of the main phenotypes Crohn's disease (CD) and ulcerative colitis (UC) are chronic diseases characterized by periods of relapse and remission. IBD negatively affects patients' physical, psychological, familial, and social life and so is often disabling. 1 Much research has been undertaken on patient-reported outcomes that measure the impact of disease activity and severity on patients' well-being. Quality of life is subjective and focuses on how the person feels about their functional restrictions. 2, 3 The Inflammatory Bowel Disease Disability Index (IBD-DI), in contrast, measures disability, which is defined by the World Health Organization as "any restriction or lack (resulting from any impairment) of ability to perform an activity in the manner or within the range considered normal for a human being". 2 The IBD-DI was developed by four preparatory studies (a systematic literature review, a qualitative study, an expert survey, and a cross-sectional study) followed by a consensus conference attended by 20 experts in the field who settled on a 28-item tool. 3 It has been validated for use as a clinical interview, and it has subsequently been used in various studies. 1, 2, [4] [5] [6] [7] [8] [9] [10] [11] [12] A study with 166 participants reported that the IBD-DI correlated with the CD activity index (r = À0.77, P < 0.001), partial Mayo score (r = À0.82, P < 0.001), and Inflammatory Bowel Disease Questionnaire (r = 0.86, P < 0.001). 2 The IBD-DI has been recommended to become a major secondary endpoint in clinical practice and clinical trials. 3 While the IBD-DI has been validated for use as a clinical interview, a self-report version has not been developed as yet. A self-report version would increase the capacity of the IBD-DI to be used by reducing reliance on administration by a clinician or interviewer, allowing for completion at home and permitting easier follow-up of patients in drug trials.
A recent study tested a self-report version of the IBD-DI in a population-based cohort by assessing construct validity. A strong correlation was found between the IBD-DI for self-report and the Work and Social Adjustment Scale, World Health Organization Disability Assessment, Kessler Psychological Distress Scale, and Inflammatory Bowel Disease Questionnaire. 5 However, the previous study did not compare the self-report version to the gold standard of the clinical interview, which is a fundamental component of validating an instrument for self-report. Our study aims to compare the IBD-DI self-report version (IBD-DI-SR) to the standardized clinical interview version. Because the original IBD-DI consisted of 28 items, we aim to create an item-reduced version of the IBD-DI in order to improve efficiency and reduce questionnaire fatigue.
Methods
Phase 1: Recruitment and data collection
Instruments
Inflammatory Bowel Disease Disability Index clinical interview version. The clinical interview version of the IBD-DI consists of 19 items divided into 28 parts covering the five domains of overall health, body function, body structures, activity participation, and environmental factors. 3 It explores the severity of disability and limitations in the domains of sleeping, mood, abdominal pain, bowel frequency, regulating defecation, participation in social events and work or school, and exacerbating effects of medication, food, family, and health-care professionals. Scoring is available from Leong et al. 2 The response of each item on the questionnaire is either dichotomous "yes" versus "no" or ordinal on a 1 to 5 Likert scale (1 being no difficulty and 5 being extreme difficulty, or 1 being no positive/negative effect and 5 being extreme positive/negative effect and not applicable). The overall disability score ranges from À80 (maximum disability) to +22 (no disability), with "0" as the anticipated point of neutrality.
Inflammatory Bowel Disease Disability Index self-report version. The IBD-DI-SR (Appendix I) had the wording modified to reflect the fact the patients are answering it themselves. Language was graded as equivalent to 8th to 9th grade according to the Flesch Reading Ease score. 13 The items are numbered from 1 to 29, with separate questions for height and weight combined later into BMI.
Participants. In this multicenter, cross-sectional observational study, patients were recruited between April and August 2017, from the gastroenterology outpatient clinics in Christchurch Hospital, New Zealand and Concord Hospital, Sydney, Australia.
Consecutive patients who were 18 years or older, were diagnosed with IBD (UC or CD), had sufficient English comprehension, and were able to complete the questionnaire and clinical interview were prospectively included. The following disease characteristics were collected for every patient: age, gender, disease type, years since diagnosis, and medication. Ethical approval has been received by the Sydney Local Health District Human Research Ethics Committee (Reference LNR/17/CRGH/111) and New Zealand Health and Disability Ethics Committee (Reference 17/CEN/5/AM01).
Procedure. Figure 1 shows the flow of participants through the study. Christchurch Hospital and Concord Hospital Gastroenterology outpatient clinic lists were scanned 3 weeks in advance. Therefore, mostly patients attending routine follow-up appointments were included. Patients with IBD were contacted by telephone and asked if they were interested in participating in the research. Following verbal consent, subjects were randomized 1:1 to either questionnaire first or clinical interview first. Patients were randomized using a document made by the statistician with either "clinical interview first" or "self-report first" in a random order.
An envelope with the study information sheet and consent form was posted to participants. Participants who were randomized to do the IBD-DI-SR first had the questionnaire posted to them requesting they complete it 3 to 7 days before clinic. A text message was then sent 7 days before their outpatient appointment to remind them to complete the questionnaire. The clinical interview was performed before or after the outpatient appointment. Those randomized to do the clinical interview first had the clinical interview performed at the outpatient clinic and were sent home with the IBD-DI-SR. Instructions were to complete it in 3 to 7 days after clinic and send it back. A reminder text message was sent 3 days after clinic.
The IBD-DI was administered in a face-to-face interview. In case of patients who confirmed they wanted to participate during clinic in Sydney and were randomized to self-report first, some phone interviews were performed. A link on the pen-and-paper questionnaire to the online version on Questionpro was available if participants preferred to complete the IBD-DI-SR online.
To ensure consistency between the research staff and consultant gastroenterologists, six patients completed the clinical interview twice: once with the gastroenterologist and once with the researcher. Patients of both randomized conditions (clinical interview first or self-report first) were interviewed twice and in different sequences (researcher first or doctor first).
Phase 2: Validation of the Inflammatory Bowel Disease Disability Index self-report version and development of an item-reduced scale
Clinical interview versus 28-item self-report. The total scores for IBD-DI-SR and the IBD-DI were correlated using a Pearson correlation coefficient. Internal consistency of the IBD-DI-SR was measured using Cronbach's α. Additional analyses of the IBD-DI were performed comparing the two randomization sequences and face-to-face interview compared with phone interview, to determine whether these factors were impacting on the scale. These analyses were undertaken using ANOVA.
Item-reduction Inflammatory Bowel Disease Disability Index self-report version. To determine whether the number of items of the IBD-DI-SR could be reduced, the individual 28 selfreport items were correlated with the clinician total score, and the face validity and item variance were assessed.
Correlation with clinician total score. Pearson correlation coefficients were used to evaluate the magnitude and direction of the statistical relationships between the self-report items and the total score of the IBD-DI.
Face validity. Face validity was defined as the "appropriateness, sensibility or relevance of the test and its items as they appear to the persons answering the test." 14 Additionally, feedback on the individual questions was asked from the respondents during the clinical interviews. For example, questions that were reported by patients to be not clear, not relevant, or not appropriate were judged as having low face validity.
Variance. To demonstrate that there was sufficient variation in the responses to the self-report items, the variance for each item was calculated. A variance of < 0.5 indicates in this context insufficient variability in the responses to make the item useful for discriminating patients with varying degrees of disability.
Multiple regression. A multiple linear regression analyses was used to determine the independent contributions of the individual IBD-DI-SR items in predicting the clinician total score. Questions with low correlations with the IBD-DI, low face validity, or little variance were not included in the multiple regression. The R 2 from Disability index for self-reportthe model was used to determine the overall association between the item-reduced IBD-DI-SR and the IBD-DI.
Statistics. Statistical analyses were undertaken using SPSS v24.0, and a P-value < 0.05 denoted statistical significance. Power calculation was based on the ability to have > 90% power to detect correlations of > 0.3 as statistically significant (two-tailed P-value < 0.05) and therefore at least 100 patients needed to be included.
Results
Patient characteristics. One hundred seventy-four patients were approached for the study in Sydney and Christchurch, of whom 150 patients gave verbal consent (Fig. 2) . A total of 120 patients completed the study (response rate of 69.0%). We included 114 patients for the final analysis. Table 1 shows the demographics and clinical information about the patients. Half were from Christchurch. Sixty-three had CD, and 51 had UC. Fifty-six percent was female. The mean age was 40 years and the mean disease duration 10 years. Only face-to-face interviews were performed in Christchurch; Sydney completed 14 clinical interviews by phone.
Clinical interview versus 28-item self-report. There was no statistically significant difference in data obtained by the research assistant-administered interview versus specialist administration in correlating total scores of the IBD-DI on paired analyses (Fig. S1) .
The Pearson correlation coefficient of the IBD-DI total with the IBD-DI-SR total was 0.90 (P < 0.001), which means that the IBD-DI-SR explains 80% of the variance of the IBD-DI. Internal consistency was high for the IBD-DI-SR (Cronbach's α = 0.86) and the IBD-DI (Cronbach's α = 0.82).
Different randomization orders had no effect on the total scores of the IBD-DI. The mean total score of the IBD-DI for the self-report first group was À5.47 (±13.22) and for the clinical interview first was À6.69 (±11.19), P = 0.60. The mean total score of the IBD-DI-SR for the self-report first group was À5.43 (±13.45) and for the clinical interview first was À4.43 (±13.47), P = 0.69. Phone administration of the IBD-DI interview (mean total score of the IBD-DI: À3.71 ± 11.00) was not significantly different to face-to-face interview (À6.46 ± 12.30), P = 0.43.
Christchurch and Sydney did not differ in terms of mean IBD-DI clinical interview (À7.77 ± 11.85 vs À4.40 ± 12.23, P = 0.14) scores or IBD-DI-SR (À6.30 ± 14.02 vs À3.40 ± 12.75, P = 0.25) scores. CD and UC did not differ for IBD-DI (À6.95 ± 10.7 vs À5.02 ± 13.69, P = 0.40) or IBD-DI-SR (À6.190 ± 13.32 vs À3.20 ± 13.49, P = 0.24). Item-reduction Inflammatory Bowel Disease Disability Index self-report version. Table 2 summarizes the 28 self-report items with respect to the correlations with the clinician total score, face validity, and variance. Questions 15 + 16, 17, 20, 21, 24, 27, 28, and 29 were poorly correlated with the clinician total score, all rs < 0.3. Questions 23 and 27 were respectively the positive and negative effects of recent advice from health professionals and were generally not considered relevant by patients in contributing to their IBD-related disability. For question 26, the negative effect of family was also not considered to add extra value to the measurement of disability and did not add to the information obtained from the positively worded question 22. Question 28 about social security was considered ambiguous by many patients. It was unclear to patients whether the emphasis was on the yes or no benefitting from or needing the support; additionally, the meaning of social security was unclear. Therefore, questions 23, 26, 27, and 28 had poor face validity. Questions 17, 24, 27, and 29 all had very low variance (< 0.5). In total, 10 self-report items were excluded because they had a low correlation with the clinician total, poor face validity, or low variance.
Multiple regression. We included 18 self-report questions in a multiple regression model (Fig. 3) . The self-report questions that optimally predicted the clinician total score with all items independently contributing were questions 1, 4, 5, 7, 12, 14, 18, and 22. Expert opinions were gained by asking two consultant gastroenterologists and one expert patient about adding extra questions to the 8-item model, which would be of clinical relevance. No extra items were added to the model.
Final item-reduced model. The 8-item model with the included questions 1, 4, 5, 7, 12, 14, 18, and 22 had an R 2 = 0.77 (Fig. S2) . The items are all significant predictors (P < 0.05) of the dependent variable total clinician score (Table 3) . Figure 4 shows the final item-reduced IBD-DI-SR. The total score of the item-reduced IBD-DI-SR ranges from À26 (maximum disability) to +6 (no disability) (Appendix II). The Pearson correlation coefficient between the mean total score of the item-reduced IBD-DI-SR and the full 28-item self-report score was 0.92. This shows that the removal of the 20 items did not materially affect the total self-report score.
Discussion
The aim of this project was to validate the IBD-DI-SR and reduce the number of items used. The IBD-DI-SR showed high internal consistency, interobserver reliability, and a high correlation Disability index for self-reportcompared with the IBD-DI for clinical interview. Therefore, the IBD-DI-SR demonstrated excellent reliability and validity. The IBD-DI-SR was reduced from 28 items to 8, which is less than a third of the questions. These eight questions explain 77% of the total questionnaire variance. An item-reduced self-report English version of the IBD-DI is more usable because it takes less time for completion and may increase research ease and capacity. The strengths of our study are the methods used to validate the IBD-DI for self-report. This study compared the IBD-DI-SR with the gold standard, eliminated potential for bias randomizing participants (i.e. self-report or clinical interview first), tested interobserver reliability, collected data from two different centers (increasing generalizability), and improved the utility of the tool by simplification of the language and item-reduction of the IBD-DI-SR.
Limitations and future directions. This study has several limitations that relate directly to the method of the study and to the questionnaire itself. CD and UC are chronic diseases with variable clinical courses. We tried to choose a period of time between the clinical interview and self-report, which was long enough to prevent rote memorization of answers but too short to have a significant fluctuation in IBD symptoms. However, differences found might be due to disease activity, which can change over time.
A reason for the modest response rate was the time frame; a schedule for the clinical interviews was made depending on the date and time of the outpatient appointment. Nevertheless, the response rate was considered adequate for a validation study.
We did not collect data regarding disease activity, comorbid diseases-for example, irritable bowel syndrome and depressionmedicines for IBD, and food intake that could have influenced the IBD-DI scores. Future studies should study these factors.
When conducting the clinical interviews and receiving the IBD-DI-SRs, feedback of patients led to the observation that while the IBD-DI claims to be IBD specific, 2,3 the questionnaire did not state explicitly that participants were supposed to answer the questions within the context of their IBD. The phrase "inflammatory bowel disease" is not mentioned in the instructions nor questions the interviewer has to read out loud to the patient. Therefore, it is possible that patients answered the questions generally and not in the context of IBD. In the item-reduced IBD-DI-SR, the words "inflammatory bowel disease" and "IBD" were subsequently added to the instructions to clarify the intention of the IBD-DI-SR tool.
A question on the health care needed did not achieve variance in the results with 95% answering "yes." A question on social security system was also found to be ambiguous. It was not clear if the emphasis was put on benefitting from or needing the support, but most importantly, the meaning of the social security system was questioned. In New Zealand and/or Australia, the model of health-care delivery and social support differs from other countries, and therefore, the answers to this question can have a different effect on disability. This question was excluded from the item-reduced IBD-DI-SR due to its low correlation with the total IBD-DI score, poor face validity, and the likelihood of bias based on a country's health-care system or use of social security. Two different scoring systems for the IBD-DI are available. This study used the validated scoring system of Leong et al., 2 and an alternative scoring key was published afterwards. 1 The scoring keys of Leong et al. 4, 7, 8, 10 and Gower-Rousseau et al. 5, 6, 11, 12 both have been used in recent papers. Future users need to be aware of this.
Two patients with stomas were excluded because no answer to question 14 about stool frequency was available for stoma patients in the scoring system that was used. 2 The answers should be adjusted to be able to include these patients because having a stoma is a not a rare condition in IBD patients.
In earlier research, cut-offs for different severities of disability (e.g. no disability, mild disability, moderate disability, and severe disability) were either based on the interquartile range of the Figure 4 The item-reduced Inflammatory Bowel Disease Disability Index self-report version.
Disability index for self-reportIBD-DI total score that was evaluated at population level 1 or correlated with the hours worked in the last week. 2 In future research, cut-offs for the IBD-DI-SR score should ideally be determined through population-based studies using different disease scales and disability instruments. The IBD-DI-SR needs validation in a large prospective cohort.
Conclusion. The IBD-DI-SR demonstrated excellent reliability and validity. The IBD-DI-SR showed high internal consistency and a high correlation coefficient compared with the IBD-DI. We have developed the item-reduced IBD-DI-SR, which contains eight items explaining 77% of the variance. The measure of disability is now more widely usable due to its brevity and elimination of the need for a clinician to perform an interview. Limitations in the wording and scoring system need to be addressed, and cut-offs describing different levels of disability according to the total score of the item-reduced IBD-DI-SR should be investigated. Disability is an important patient-reported outcome, and this tool should be more widely used to explore treatments that improve activity participation and overall functioning in IBD patients.
Please rate the extent to which the following aspects of your environment positively or negatively influenced your disease activity, bodily functions, and daily activities. 
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Additional supporting information may be found online in the Supporting Information section at the end of the article. Figure S1 . Inter-observer reliability: correlation between the total scores of the IBD-DI between the specialist and research staff. Figure S2 . The correlation between the total scores of the IBD-DI and the total scores of the item-reduced IBD-DI-SR, with R 2 = 0.77.
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